Suppr超能文献

慢性阻塞性肺疾病-哮喘重叠综合征

The chronic obstructive pulmonary disease-asthma overlap syndrome.

作者信息

Braman Sidney S

机构信息

Ichan School of Medicine of Mount Sinai, New York, New York, USA.

出版信息

Allergy Asthma Proc. 2015 Jan-Feb;36(1):11-8. doi: 10.2500/aap.2015.36.3802.

Abstract

When asthma and chronic obstructive pulmonary disease (COPD) occur together the term COPD-asthma overlap syndrome has been applied. To date, there is no universally accepted definition of this overlap syndrome, just as there is no blood test or other technologic assessment that provides a simple way to distinguish asthma from COPD. One practical approach to the overlap diagnosis has been to include patients with a diagnosis of COPD by Global Initiative for Chronic Obstructive Lung Disease criteria and asthma defined by subject report of a physician diagnosis of asthma before the age of 40 years. Alternatively, it includes patients who meet criteria for COPD (fixed airflow obstruction) and who also have typical features of asthma (wheezing, atopy, eosinophilia, and positive bronchodilator response on spirometry). Compared with patients with COPD alone, the overlap patients are younger with less smoking intensity, have higher health-care utilization, have a worse disease-related quality of life, and have a higher mortality. Treatment with corticosteroids earlier in the course of the disease compared with the patient with only COPD has been recommended.

摘要

当哮喘与慢性阻塞性肺疾病(COPD)同时出现时,就使用了“COPD-哮喘重叠综合征”这一术语。迄今为止,对于这种重叠综合征尚无普遍接受的定义,正如没有血液检查或其他技术评估能够提供一种简单方法来区分哮喘和COPD一样。重叠诊断的一种实用方法是纳入符合慢性阻塞性肺疾病全球倡议标准的COPD诊断患者,以及在40岁之前由医生诊断为哮喘且有哮喘症状报告的患者。或者,它包括符合COPD标准(固定性气流受限)且同时具有哮喘典型特征(喘息、特应性、嗜酸性粒细胞增多以及肺功能测定时支气管扩张剂反应阳性)的患者。与单纯COPD患者相比,重叠患者更年轻,吸烟强度更低,医疗保健利用率更高,疾病相关生活质量更差,死亡率更高。与仅患有COPD的患者相比,建议在疾病进程中更早地使用皮质类固醇进行治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验